Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1

Inclusion Criteria: * The patient is female, 18 to 65 years of age, inclusive. * The patient has a diagnosis of primary FM as defined by the 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria (American College of Rheumatology Preliminary Diagnostic Criteria) * The in clinic 7-day recall VAS scale average daily pain intensity score at Screening visit within protocol defined range. Exclusion Criteria: * Any underlying medical or psychiatric condition that could impact their safe participation per protocol.